RxDoctor Payments Data

Aliza Solomon

Pediatric Gastroenterology · Forest Hills, NYNPI 1619136637

Payments from drug & device makers

What this record shows

Takeda Pharmaceuticals U.S.A., Inc. accounts for 73.6% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,915, more than ten times the $157 reported in 2019.

$2,195in general payments, 2019–2025

Across 22 payments — averaging $99.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$2K
  • Sanofi$298
  • AbbVie$151
  • QOL Medical, LLC$76
  • Regeneron Healthcare Solutions, Inc.$53
$406,866in research payments, 2019–2025

Across 69 payments — averaging $5896.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$216K
  • Regeneron$87K
  • Janssen Research & Development, LLC$70K
  • Takeda Pharmaceuticals U.S.A., Inc.$31K
  • UCB Biosciences Inc.$3K

What the payments were for

  • Travel & lodging$1,29759%
  • Food & beverage$89941%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,195 in reported general payments places this provider in the 70th percentile of 143 pediatric gastroenterology providers in New York.

See all pediatric gastroenterology providers in New York

Other pediatric gastroenterology in Forest Hills

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →